Combination antiretroviral therapy (ART) has transformed HIV-1 infection into a chronic condition with near-normal life expectancy. For more than two decades, the standard regimen has been a ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

Next-day HIV viral load test results do not improve overall linkage to care when added to standard testing but are tied to ...

On World AIDS Day the World Health Organization (WHO) emphasizes that expanding antiretroviral therapy to all people living with HIV is key to ending the AIDS epidemic within a generation. “The ...

Explore the latest advancements in HIV therapy and how enhanced immune cells can improve treatment outcomes for patients.

A study of more than 50 babies in Africa, Asia, North America and South America has added substantially to evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first ...

Researchers examined the incidence of hepatitis B reactivation and incident infection after switching to long-acting cabotegravir plus rilpivirine among patients with HIV.

Background: Current guidelines for the use of antiretroviral (ARV) therapy during pregnancy recommend that women be offered treatment with combination ARV therapy used in nonpregnant HIV-infected ...

Earlier antiretroviral therapy was found to be safe in regards to kidney health, with benefits of virologic suppression and immune reconstitution. Acute kidney injury and chronic kidney disease (CKD) ...

The report categorizes the global antiretroviral therapy market by drug class that includes multiclass combination products, NRTIs, integrase inhibitors, and NNRTIs. The report also determines the ...